Importance The increasing use of neoadjuvant chemotherapy (NAC) for operable breast
cancer has raised questions about optimal local therapy for the axilla. Observations Sentinel …

Background Neoadjuvant chemotherapy (NAC) downstages axillary disease in 55% of node-
positive (N1) breast cancer. The feasibility and accuracy of sentinel lymph node biopsy …

Background The optimal strategy for incorporating lymphatic mapping and sentinel lymph
node biopsy into the management of breast cancer patients receiving neoadjuvant …

Background The oncologic safety of sentinel lymph node biopsy (SLNB) alone for clinically
node-positive (cN1–2) patients who convert to pathologic node-negativity (ypN0) after …

Objective: The aim of this study was to perform a systematic review and meta-analysis to
assess the accuracy of different surgical axillary staging procedures compared with ALND …

BACKGROUND The use of sentinel lymph node biopsy (SLNB) following neoadjuvant
chemotherapy (NAC) in patients presenting with clinically positive lymph nodes remains …

Background Neoadjuvant chemotherapy (NAC) may downstage axillary disease in node-
positive breast cancer. Several clinical trials have shown that sentinel lymph node (SLN) …

The sentinel lymph node biopsy (SLNB) is now an accepted alternative to the axillary lymph
node dissection for pathologic evaluation of the axilla in patients with early breast cancer …

Background Recent trials have suggested the feasibility of performing a sentinel lymph node
biopsy (SNB) following neoadjuvant chemotherapy (NAC). The selection of suitable patients …

Objective: Sentinel lymph node (SLN) surgery is widely used for nodal staging in early-stage
breast cancer. This study was performed to evaluate the accuracy of SLN surgery for …